Candel Therapeutics, Inc. (CADL)
6.20
-2.19
(-26.10%)
USD |
NASDAQ |
Nov 13, 16:00
6.05
-0.15
(-2.42%)
After-Hours: 19:59
Candel Therapeutics Net Income (Quarterly) : -21.87M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -21.87M |
| June 30, 2026 | -38.90M |
| March 31, 2026 | -8.861M |
| December 31, 2025 | -29.50M |
| September 30, 2025 | -11.27M |
| June 30, 2025 | -4.796M |
| March 31, 2025 | 7.379M |
| December 31, 2024 | -14.07M |
| September 30, 2024 | -10.65M |
| June 30, 2024 | -22.24M |
| March 31, 2024 | -8.221M |
| December 31, 2023 | -11.10M |
| September 30, 2023 | -8.435M |
| June 30, 2023 | -9.614M |
| Date | Value |
|---|---|
| March 31, 2023 | -8.795M |
| December 31, 2022 | -5.083M |
| September 30, 2022 | -8.688M |
| June 30, 2022 | -4.149M |
| March 31, 2022 | -0.874M |
| December 31, 2021 | 1.596M |
| September 30, 2021 | -16.16M |
| June 30, 2021 | -17.08M |
| March 31, 2021 | -4.478M |
| December 31, 2020 | -10.48M |
| September 30, 2020 | -2.554M |
| June 30, 2020 | -2.876M |
| March 31, 2020 | -1.772M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Oragenics, Inc. | -2.603M |
| Arcturus Therapeutics Holdings, Inc. | -7.414M |
| ACADIA Pharmaceuticals, Inc. | 53.52M |
| Alnylam Pharmaceuticals, Inc. | 2.167B |
| Anika Therapeutics, Inc. | -0.311M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 21.87M |
| EPS Diluted (Quarterly) | -0.2826 |
| Enterprise Value | 333.02M |
| Earnings Yield | -23.98% |
| Normalized Earnings Yield | -20.84 |